Editorial
Predicting response to chemoradiotherapy in rectal cancer: are we there yet?
Ian Lindsey,
Ian Lindsey
Department of Colorectal Surgery, Oxford Pelvic Floor Centre, Churchill Hospital, Oxford, UK
Search for more papers by this authorIan Lindsey,
Ian Lindsey
Department of Colorectal Surgery, Oxford Pelvic Floor Centre, Churchill Hospital, Oxford, UK
Search for more papers by this authorNo abstract is available for this article.
References
- 1Zorcolo L, Rosman AS, Restivo A et al. Complete pathologic response after combined modality treatment for rectal cancer and long-term survival: a meta-analysis. Ann Surg Oncol 2012; 19: 2822–32.
- 2Hompes R, Cunningham C. Extending the role of Transanal Endoscopic Microsurgery (TEM) in rectal cancer. Colorectal Dis 2011; 13(Suppl 7): 32–6.
- 3Habr-Gama A, Sabbaga J, Gama-Rodrigues J et al. Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management? Dis Colon Rectum 2013; 56: 1109–17.
- 4Genovesi D, Filippone A, Ausili Cèfaro G et al. Diffusion-weighted magnetic resonance for prediction of response after neoadjuvant chemoradiation therapy for locally advanced rectal cancer: preliminary results of a monoinstitutional prospective study. Eur J Surg Oncol 2013; 39: 1071–8.
- 5Walter CJ, Bell LT, Parsons SR, Jackson C, Borley NR, Wheeler JM. Prevalence and significance of anaemia in patients receiving long-course neoadjuvant chemoradiotherapy for rectal carcinoma. Colorectal Dis 2013; 15: 52–6.
- 6Yasuda K, Sunami E, Kawai K, Nagawa H, Kitayama J. Laboratory blood data have a significant impact on tumor response and outcome in preoperative chemoradiotherapy for advanced rectal cancer. J Gastrointest Cancer 2012; 43: 236–43.
- 7Lee SD, Park JW, Park KS et al. Influence of anemia on tumor response to preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2009; 24: 1451–8.
- 8Berardi R, Braconi C, Mantello G et al. Anemia may influence the outcome of patients undergoing neo-adjuvant treatment of rectal cancer. Ann Oncol 2006; 17: 1661–4.
- 9Box B, Lindsey I, Wheeler JM et al. Neoadjuvant therapy for rectal cancer: improved tumor response, local recurrence, and overall survival in nonanemic patients. Dis Colon Rectum 2005; 48: 1153–60.
- 10Khan AA, Klonizakis M, Shabaan A, Glynne-Jones R. Association between pretreatment haemoglobin levels and morphometric characteristics of the tumour, response to neoadjuvant treatment and long-term outcomes in patients with locally advanced rectal cancers. Colorectal Dis 2013; 15: 1232–7.
- 11Cata JP, Wang H, Gottumukkala V, Reuben J, Sessler DI. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br J Anaesth 2013; 110: 690–701.
- 12Lambin P, Ramaekers BL, van Mastrigt GA et al. Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database Syst Rev 2009; 3: CD006158.
- 13Fitzgerald JE, Simpson JA, Acheson AG. The use of intravenous iron in patients with cancer related anaemia: don't overlook iron deficiency anaemia in colorectal cancer. Br J Haematol 2008; 143: 754.
Citing Literature
